These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 21617196

  • 1. Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity.
    Stummvoll GH, Schmaldienst S, Smolen JS, Derfler K, Biesenbach P.
    Nephrol Dial Transplant; 2012 Feb; 27(2):618-26. PubMed ID: 21617196
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
    Biesenbach P, Schmaldienst S, Smolen JS, Hörl WH, Derfler K, Stummvoll GH.
    Atheroscler Suppl; 2009 Dec 29; 10(5):114-21. PubMed ID: 20129388
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
    Akhter E, Burlingame RW, Seaman AL, Magder L, Petri M.
    Lupus; 2011 Oct 29; 20(12):1267-74. PubMed ID: 21813587
    [Abstract] [Full Text] [Related]

  • 6. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP.
    Arthritis Rheum; 2006 Sep 29; 54(9):2951-62. PubMed ID: 16947629
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C, Börjesson-Asp K, Zendjanchi K, Sundqvist AC, Tarkowski A, Bokarewa M.
    J Rheumatol; 2008 May 29; 35(5):826-33. PubMed ID: 18398943
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
    Reichlin M, Broyles TF, Hubscher O, James J, Lehman TA, Palermo R, Stafford HA, Taylor-Albert E, Wolfson-Reichlin M.
    Arthritis Rheum; 1999 Jan 29; 42(1):69-75. PubMed ID: 9920016
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC.
    Arthritis Res Ther; 2006 Jan 29; 8(6):R162. PubMed ID: 17062137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.